We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
(+60%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
34.53%
Top 10 Holdings %
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.52M |
| 2 |
Keurig Dr Pepper
KDP
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.19M |
| 4 |
AET
Aetna Inc
AET
|
+$2.17M |
| 5 |
PNC Financial Services
PNC
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$1.39M |
| 2 |
Eaton
ETN
|
+$1.38M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$1.35M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$1.32M |
| 5 |
DaVita
DVA
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.9% |
| 2 | Consumer Discretionary | 14.51% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 13.03% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STR
301
DELISTED
QUESTAR CORP
STR
| $203K | 0.09% |
+8,200
| New | +$189K |
|
302
Fomento Económico Mexicano
FMX
$41.2B
| $202K | 0.09% |
2,100
+1,200
| +133% | +$110K |
|
303
Watsco Inc
WSO
$13.2B
| $202K | 0.09% |
1,500
+1,100
| +275% | +$133K |
|
304
NXP Semiconductors
NXPI
$60.8B
| $199K | 0.08% |
2,450
+2,200
| +880% | +$164K |
|
|
ALR
305
DELISTED
Alere Inc
ALR
| $197K | 0.08% |
3,900
-1,200
| -24% | -$57.5K |
|
|
BBL
306
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $197K | 0.08% |
8,648
+7,747
| +860% | +$162K |
|
|
ETFC
307
DELISTED
E*Trade Financial Corporation
ETFC
| $196K | 0.08% |
+8,023
| New | +$194K |
|
308
Ally Financial
ALLY
$13.1B
| $195K | 0.08% |
10,412
+6,700
| +180% | +$115K |
|
309
Aramark
ARMK
$15B
| $195K | 0.08% |
8,172
-16,343
| -67% | -$375K |
|
310
TransDigm Group
TDG
$70.7B
| $195K | 0.08% |
+885
| New | +$193K |
|
|
WWAV
311
DELISTED
The WhiteWave Foods Company
WWAV
| $195K | 0.08% |
4,797
+2,200
| +85% | +$83.6K |
|
312
Chubb
CB
$140B
| $193K | 0.08% |
+1,620
| New | +$186K |
|
313
Kinder Morgan
KMI
$70.9B
| $193K | 0.08% |
10,808
-39,200
| -78% | -$641K |
|
314
RenaissanceRe
RNR
$13.8B
| $192K | 0.08% |
+1,600
| New | +$182K |
|
|
ANAC
315
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $192K | 0.08% |
+3,600
| New | +$266K |
|
|
MDVN
316
DELISTED
MEDIVATION, INC.
MDVN
| $191K | 0.08% |
4,162
+900
| +28% | +$32.6K |
|
|
IMS
317
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $191K | 0.08% |
+7,200
| New | +$179K |
|
318
Lear
LEA
$7.39B
| $189K | 0.08% |
1,700
-1,500
| -47% | -$159K |
|
319
Conagra Brands
CAG
$7.42B
| $188K | 0.08% |
5,427
-23,529
| -81% | -$764K |
|
320
Agilent Technologies
A
$39.6B
| $187K | 0.08% |
4,706
-6,700
| -59% | -$255K |
|
321
H&R Block
HRB
$5.98B
| $187K | 0.08% |
7,063
+3,700
| +110% | +$116K |
|
|
ADT
322
DELISTED
ADT Corp
ADT
| $187K | 0.08% |
4,539
+3,900
| +610% | +$137K |
|
|
ARMH
323
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $183K | 0.08% |
+4,186
| New | +$175K |
|
|
LM
324
DELISTED
Legg Mason, Inc.
LM
| $180K | 0.08% |
+5,179
| New | +$162K |
|
325
GameStop
GME
$9.8B
| $171K | 0.07% |
21,604
+10,540
| +95% | +$75.8K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.
- Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
- Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
- Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
- Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
- Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
- Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.
Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.